Relmada Therapeutics Inc (RLMD)

Jan 05, 2026

Analyzing Citius Pharmaceuticals (NASDAQ:CTXR) and Relmada Therapeutics (NASDAQ:RLMD) - Defense World

Jan 05, 2026

Jan 03, 2026

Corient Private Wealth LLC Invests $120,000 in Relmada Therapeutics, Inc. $RLMD - Defense World

Jan 03, 2026

Jan 02, 2026

Small Cap Biotech In 2025: Winning Pivots And Zombie Killers - Citeline News & Insights

Jan 02, 2026

Jan 02, 2026

Relmada’s BOOST Phase 3 Bladder Cancer Trial Sets Up a New Catalyst for RLMD Investors - TipRanks

Jan 02, 2026

Dec 31, 2025

Relmada Therapeutics, Inc. (NASDAQ:RLMD) Short Interest Update - Defense World

Dec 31, 2025

Dec 24, 2025

Jefferies Financial Group Begins Coverage on Relmada Therapeutics (NASDAQ:RLMD) - Defense World

Dec 24, 2025

Dec 23, 2025

Relmada Therapeutics (NASDAQ:RLMD) Stock Rating Upgraded by Jefferies Financial Group - MarketBeat

Dec 23, 2025

Dec 22, 2025

Jefferies Initiates Coverage of Relmada Therapeutics (RLMD) with Buy Recommendation - Nasdaq

Dec 22, 2025

Dec 22, 2025

Relmada Therapeutics (RLMD) Initiates Coverage with Buy Rating | RLMD Stock News - GuruFocus

Dec 22, 2025

Dec 22, 2025

This Blacksky Technology Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga

Dec 22, 2025

Dec 22, 2025

Treasury Yields: Is NEHC stock recession proof2025 Trading Recap & Weekly Stock Breakout Alerts - moha.gov.vn

Dec 22, 2025

Dec 22, 2025

Jefferies initiates Relmada Therapeutics stock with Buy rating on pipeline pivot - Investing.com Nigeria

Dec 22, 2025

Dec 22, 2025

Jefferies initiates Relmada Therapeutics stock with Buy rating on pipeline pivot By Investing.com - Investing.com South Africa

Dec 22, 2025

Dec 22, 2025

Jefferies Starts Relmada Therapeutics Inc (RLMD) at Buy - StreetInsider

Dec 22, 2025

Dec 20, 2025

Will Relmada Therapeutics Inc. stock benefit from infrastructure spendingJuly 2025 Movers & Weekly Momentum Stock Picks - Улправда

Dec 20, 2025

Dec 20, 2025

Inflation Data: Will Las Vegas Sands Corp stock outperform value peersPortfolio Return Summary & Real-Time Market Sentiment Reports - moha.gov.vn

Dec 20, 2025

Dec 20, 2025

Will Relmada Therapeutics Inc. (4E2) stock outperform energy sector in 2025Product Launch & Entry Point Confirmation Signals - Улправда

Dec 20, 2025

Dec 20, 2025

Is Relmada Therapeutics Inc. stock supported by strong cash flowsPortfolio Growth Summary & Entry Point Confirmation Alerts - Улправда

Dec 20, 2025

Dec 20, 2025

Why Relmada Therapeutics Inc. stock remains undervalued2025 Buyback Activity & Real-Time Buy Zone Alerts - Улправда

Dec 20, 2025

Dec 19, 2025

Momentum Shift: Why Relmada Therapeutics Inc. (4E2) stock benefits from AI revolution2025 Performance Recap & Low Risk Growth Stock Ideas - Улправда

Dec 19, 2025

Dec 19, 2025

Recap Report: Is Relmada Therapeutics Inc. stock supported by strong cash flowsBond Market & AI Enhanced Trading Alerts - Улправда

Dec 19, 2025

Dec 19, 2025

How supply chain issues affect Relmada Therapeutics Inc. stockJuly 2025 Macro Moves & Safe Entry Trade Reports - Улправда

Dec 19, 2025

Dec 19, 2025

How Relmada Therapeutics Inc. (4E2) stock moves in volatile trading sessions2025 Trade Ideas & Free Expert Verified Stock Movement Alerts - Улправда

Dec 19, 2025

Dec 18, 2025

Is Relmada Therapeutics Inc. stock supported by innovation pipeline2025 Market Trends & Reliable Intraday Trade Alerts - Улправда

Dec 18, 2025

Dec 17, 2025

Have you been able to find a good deal on Relmada Therapeutics Inc’s shares? - uspostnews.com

Dec 17, 2025

Dec 16, 2025

RelmadaA New Contender To Watch In Bladder Cancer Drug Development? - RTTNews

Dec 16, 2025

Dec 16, 2025

Maged Shenouda Increases Stake in Relmada Therapeutics Inc (RLMD) - GuruFocus

Dec 16, 2025

Dec 16, 2025

Relmada Therapeutics (NASDAQ:RLMD) CFO Buys $48,059.80 in Stock - MarketBeat

Dec 16, 2025

Dec 16, 2025

Relmada Therapeutics updates executive contracts and increases salaries By Investing.com - Investing.com Australia

Dec 16, 2025

Dec 15, 2025

Relmada Therapeutics Amends Executive Employment Agreements - TipRanks

Dec 15, 2025

Dec 15, 2025

Relmada Therapeutics updates executive contracts and increases salaries - Investing.com

Dec 15, 2025

Dec 14, 2025

What analysts say about Relmada Therapeutics Inc stockMarket Insider Reports & Exceptional Profit Growth Tips - earlytimes.in

Dec 14, 2025

Dec 13, 2025

Aug Drivers: Can Relmada Therapeutics Inc stock outperform in 2025 bull marketAnalyst Upgrade & Safe Entry Trade Reports - moha.gov.vn

Dec 13, 2025

Dec 11, 2025

Comparing BeOne Medicines (NASDAQ:ONC) & Relmada Therapeutics (NASDAQ:RLMD) - Defense World

Dec 11, 2025

Dec 09, 2025

Taking on analysts’ expectations and winning: Relmada Therapeutics Inc (RLMD) - setenews.com

Dec 09, 2025

Dec 06, 2025

Relmada Therapeutics (RLMD) Price Target Increased by 900.00% to 10.20 - Nasdaq

Dec 06, 2025

Dec 04, 2025

Can Relmada Therapeutics Inc. stock hit analyst price targetsM&A Rumor & Technical Pattern Based Signals - Newser

Dec 04, 2025

Dec 04, 2025

Will Relmada Therapeutics Inc. (4E2) stock outperform value peersJuly 2025 Chart Watch & Fast Entry High Yield Stock Tips - Newser

Dec 04, 2025

Dec 04, 2025

Will Relmada Therapeutics Inc. stock deliver strong dividend growthGap Down & Risk Adjusted Buy and Sell Alerts - Newser

Dec 04, 2025

Dec 04, 2025

Relmada Therapeutics’ Earnings Call Highlights Clinical and Financial Success - MSN

Dec 04, 2025

Dec 03, 2025

Relmada’s bladder cancer therapy shows 92% complete response rate By Investing.com - Investing.com Nigeria

Dec 03, 2025

Dec 03, 2025

Relmada’s bladder cancer therapy shows 92% complete response rate - Investing.com India

Dec 03, 2025

Dec 03, 2025

Relmada Therapeutics Advances NDV-01 for Non-Muscle Invasive Bladder Cancer with Positive Phase 2 Follow-Up Data - Quiver Quantitative

Dec 03, 2025

Dec 03, 2025

Relmada Therapeutics Announces Presentation of NDV-01 Phase 2 Data at the Society for Urologic Oncology - GlobeNewswire

Dec 03, 2025

Dec 03, 2025

A History of Outperforming Analyst Forecasts and Beating the Odds: Relmada Therapeutics Inc (RLMD) - setenews.com

Dec 03, 2025

Dec 03, 2025

Why Relmada Therapeutics Inc. (4E2) stock stays resilientRecession Risk & Trade Opportunity Analysis - Newser

Dec 03, 2025